1. Home
  2. VRME vs GNPX Comparison

VRME vs GNPX Comparison

Compare VRME & GNPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRME
  • GNPX
  • Stock Information
  • Founded
  • VRME 1999
  • GNPX 2009
  • Country
  • VRME United States
  • GNPX United States
  • Employees
  • VRME N/A
  • GNPX N/A
  • Industry
  • VRME EDP Services
  • GNPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • VRME Technology
  • GNPX Health Care
  • Exchange
  • VRME Nasdaq
  • GNPX Nasdaq
  • Market Cap
  • VRME 10.4M
  • GNPX 10.8M
  • IPO Year
  • VRME N/A
  • GNPX 2018
  • Fundamental
  • Price
  • VRME $0.69
  • GNPX $2.82
  • Analyst Decision
  • VRME Strong Buy
  • GNPX
  • Analyst Count
  • VRME 2
  • GNPX 0
  • Target Price
  • VRME $1.50
  • GNPX N/A
  • AVG Volume (30 Days)
  • VRME 215.0K
  • GNPX 521.3K
  • Earning Date
  • VRME 11-14-2025
  • GNPX 11-14-2025
  • Dividend Yield
  • VRME N/A
  • GNPX N/A
  • EPS Growth
  • VRME N/A
  • GNPX N/A
  • EPS
  • VRME N/A
  • GNPX N/A
  • Revenue
  • VRME $21,669,000.00
  • GNPX N/A
  • Revenue This Year
  • VRME N/A
  • GNPX N/A
  • Revenue Next Year
  • VRME $5.98
  • GNPX N/A
  • P/E Ratio
  • VRME N/A
  • GNPX N/A
  • Revenue Growth
  • VRME N/A
  • GNPX N/A
  • 52 Week Low
  • VRME $0.55
  • GNPX $2.77
  • 52 Week High
  • VRME $5.00
  • GNPX $63.00
  • Technical
  • Relative Strength Index (RSI)
  • VRME 35.53
  • GNPX 41.66
  • Support Level
  • VRME $0.80
  • GNPX $7.71
  • Resistance Level
  • VRME $0.91
  • GNPX $5.00
  • Average True Range (ATR)
  • VRME 0.07
  • GNPX 0.72
  • MACD
  • VRME -0.02
  • GNPX -0.38
  • Stochastic Oscillator
  • VRME 20.78
  • GNPX 1.70

About VRME VerifyMe Inc.

VerifyMe Inc together with its subsidiaries, is a traceability and customer support services provider using specialized software and process technology. The company operates a Precision Logistics Segment and an Authentication Segment to provide specialized logistics for time-and-temperature sensitive products, as well as item-level traceability, anti-diversion and anti-counterfeit protection, brand protection and enhancement technology solutions. It Generates the majority of its revenue from the Precision Logistics Segment. Through its Precision Logistics segment, it provides a value-added service for sensitive parcel management driven by a proprietary software platform that provides predictive analytics from key metrics such as pre-shipment weather analysis, flight-tracking, and Others.

About GNPX Genprex Inc.

Genprex Inc is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Its technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex's oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company's product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC.

Share on Social Networks: